Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Temoporfin 3mg/3ml solution for injection vials
0801050AKAAACAC
|
Temoporfin | Temoporfin | Malignant Disease and Immunosuppression | No data available |
|
Temozolomide 140mg capsules
0801050Y0AAAEAE
|
Temozolomide | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temozolomide 180mg capsules
0801050Y0AAAFAF
|
Temozolomide | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temozolomide 250mg capsules
0801050Y0AAABAB
|
Temozolomide | Temozolomide | Malignant Disease and Immunosuppression | No data available |
|
Temsirolimus 30mg/1.2ml inf vials and diluent
0801050AUAAAAAA
|
Temsirolimus | Temsirolimus | Malignant Disease and Immunosuppression | No data available |
|
Teriflunomide 7mg tablets
0802040ALAAABAB
|
Teriflunomide | Teriflunomide | Malignant Disease and Immunosuppression | No data available |
|
Teslac 50mg tablets
0803030T0BCAAAA
|
Teslac | Testolactone | Malignant Disease and Immunosuppression | No data available |
|
Testolactone 50mg tablets
0803030T0AAAAAA
|
Testolactone | Testolactone | Malignant Disease and Immunosuppression | No data available |
|
Teysuno 15mg/4.35mg/11.8mg capsules
0801030ADBBAAAA
|
Teysuno | Tegafur/gimeracil/oteracil | Malignant Disease and Immunosuppression | No data available |
|
Teysuno 20mg/5.8mg/15.8mg capsules
0801030ADBBABAB
|
Teysuno | Tegafur/gimeracil/oteracil | Malignant Disease and Immunosuppression | No data available |
|
Thalidomide BMS 50mg capsules
0802040AABBAAAA
|
Thalidomide Pharmion | Thalidomide (Immunomodulating) | Malignant Disease and Immunosuppression | No data available |
|
Thymoglobuline 25mg inf vials
0802020X0BBAAAA
|
Thymoglobuline | Antithymocyte immunoglobulin | Malignant Disease and Immunosuppression | No data available |
|
TICE strain Bacillus of Calmette-Guerin 12.5mg instil vials
0802040X0AAAAAA
|
Bacillus Calmette-Guerin (B.C.G.) (Immunomodulator) | Bacillus calmette-guerin (B.C.G.) | Malignant Disease and Immunosuppression | No data available |
|
Tioguanine 10mg capsules
0801030T0AAACAC
|
Tioguanine | Tioguanine | Malignant Disease and Immunosuppression | No data available |
|
Tivozanib 1340microgram capsules
0801050CVAAAAAA
|
Tivozanib | Tivozanib | Malignant Disease and Immunosuppression | No data available |
|
Tivozanib 890microgram capsules
0801050CVAAABAB
|
Tivozanib | Tivozanib | Malignant Disease and Immunosuppression | No data available |
|
Tomudex 2mg powder for solution for infusion vials
0801030Z0BBAAAA
|
Tomudex | Raltitrexed | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 1mg capsules
0801050AFAAADAD
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 1mg powder for solution for infusion vials
0801050AFAAAAAA
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 1mg/1ml solution for infusion vials
0801050AFAAAFAF
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 250microgram capsules
0801050AFAAACAC
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 4mg powder for solution for infusion vials
0801050AFAAABAB
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Topotecan 4mg/4ml solution for infusion vials
0801050AFAAAEAE
|
Topotecan | Topotecan | Malignant Disease and Immunosuppression | No data available |
|
Torisel 30mg/1.2ml concentrate for inf vials and diluent
0801050AUBBAAAA
|
Torisel | Temsirolimus | Malignant Disease and Immunosuppression | No data available |
|
Trabectedin 1mg powder for solution for infusion vials
0801050AVAAABAB
|
Trabectedin | Trabectedin | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.